| 000 | 01869 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516133552.0 | ||
| 264 | 0 | _c20130530 | |
| 008 | 201305s 0 0 eng d | ||
| 022 | _a1530-0293 | ||
| 024 | 7 |
_a10.1097/CCM.0b013e318275d014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSkrobik, Yoanna | |
| 245 | 0 | 0 |
_aFactors predisposing to coma and delirium: fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflammatory factors. _h[electronic resource] |
| 260 |
_bCritical care medicine _cApr 2013 |
||
| 300 |
_a999-1008 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B |
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xgenetics |
| 650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily G, Member 2 |
| 650 | 0 | 4 |
_aATP-Binding Cassette Transporters _xgenetics |
| 650 | 0 | 4 |
_aComa _xchemically induced |
| 650 | 0 | 4 | _aCritical Illness |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP3A _xgenetics |
| 650 | 0 | 4 |
_aDelirium _xchemically induced |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFentanyl _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypnotics and Sedatives _xadministration & dosage |
| 650 | 0 | 4 |
_aInflammation _xchemically induced |
| 650 | 0 | 4 | _aIntensive Care Units |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMidazolam _xadministration & dosage |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xgenetics |
| 650 | 0 | 4 |
_aPolymorphism, Genetic _xgenetics |
| 700 | 1 | _aLeger, Caroline | |
| 700 | 1 | _aCossette, Mariève | |
| 700 | 1 | _aMichaud, Veronique | |
| 700 | 1 | _aTurgeon, Jacques | |
| 773 | 0 |
_tCritical care medicine _gvol. 41 _gno. 4 _gp. 999-1008 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/CCM.0b013e318275d014 _zAvailable from publisher's website |
| 999 |
_c22481081 _d22481081 |
||